VRCA — Verrica Pharmaceuticals Inc · rev $10.9M

Verrica Pharmaceuticals Inc (VRCA) is a biotechnology company listed on US.

Latest reported VRCA revenue for 2026-06-30 was $10.9M. Net income was -$22.8M. VRCA currently screens at market cap $79.7M.

Use this VRCA page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the VRCA quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the VRCA SEC filings page. Lician reads the product cache first so this HTML stays unique to Verrica Pharmaceuticals Inc even when a live quote feed is slow.

Verrica Pharmaceuticals Inc latest statements (FY2025)

Latest cached year on this hub. Full VRCA income, balance, and cash tables.

  • Revenue$35.6M
  • Net Income-$17.9M
  • Total Assets$47.1M
  • Total Debt$0
  • Free Cash Flow-$17.6M

VRCA recent filings